bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.06.19.733317

BRC-2/BRCA2-RIPR-1 mediated constraints on homologous recombination execution are spatiotemporally regulated during meiosis

Abstract

Homologous recombination-dependent processing of meiotic double-strand breaks is crucial to generate functional gametes. The breast and ovarian cancer susceptibility gene BRCA2 is essential for the loading of RAD51-DMC1 recombinases at DNA breaks to allow accurate repair. Here, we identify the novel protein RIPR-1 as a binding partner of Caenorhabditis elegans BRC-2/BRCA2. RIPR-1 and BRC-2 form an obligate complex both in vitro and in vivo and display interdependent loading in developing oocytes. Loss of ripr-1 results in the complete destabilization of BRC-2, while brc-2 is only partially required to preserve RIPR-1 stability. Strikingly, we found a dramatic accumulation of RAD-51 in late pachytene cells of both ripr-1 and brc-2 nulls, unveiling a BRCA2-independent pathway for recruitment of RAD-51 at resected meiotic DNA breaks. RIPR-1 enhances BRC-2 binding to single-stranded DNA and unlike the individual components, the assembled RIPR-1-BRC-2 complex can also bind double-stranded DNA in vitro. Surprisingly, we observe that RAD-51-dependent crossover designation still occurs in absence of RIPR-1-BRC-2, indicating partial, and stage-dependent constraints on homologous recombination execution. Altogether, our work identifies a novel BRC-2 interactor and sheds new light on HR-mediated regulation of DNA repair during meiosis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Silva, N., Spirek, M., Ledvinova, M., Bhavana, N., Blazickova, J., Geetha, S., Jantsch, V., Krejci, L.. 2026-06-19. BRC-2/BRCA2-RIPR-1 mediated constraints on homologous recombination execution are spatiotemporally regulated during meiosis. https://doi.org/10.64898/2026.06.19.733317

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Senescence targeting re-enables injury-responsive repair in a human RPE aging model

Aging is associated with progressive tissue dysfunction and impaired repair after injury. In the retinal pigment epithelium (RPE), these changes contribute to age-related macular degeneration (AMD), yet the mechanisms limiting repair remain incompletely understood. Here, we establish a longitudinal human embryonic stem cell (hESC)-derived RPE aging model that recapitulates key features of aged human donor RPE and combine it with mosaic cell ablation to assess injury-responsive repair. Although aged RPE cells initiate DNA synthesis after injury, they exhibit impaired mitotic progression, uncoupling S-phase entry from epithelial repopulation. Transcriptomic profiling links this defect to a senescence-associated program marked by inflammatory signaling and suppressed mitotic networks. Pharmacologic reduction of senescent cells with Navitoclax shifts aged RPE toward a younger transcriptional profile but does not induce repopulation by itself. Instead, senolytic treatment primes aged RPE for repair, improving epithelial density and homeostatic function only in response to injury, a strategy we term "senolytic priming." These findings establish a human stem-cell-derived platform for investigating age-associated epithelial repair failure and show that aged human RPE retains latent repair capacity that can be re-enabled by targeting cellular senescence.

Cell Biology↗

Bidirectional modulation of aging-associated cellular phenotypes by mitochondrial genome replacement

Mitochondrial dysfunction is a hallmark of cellular aging, but whether age-associated cellular decline can be functionally reversed remains unclear. Here, we applied mitochondrial genome replacement to replicative senescent fibroblasts and aged T cells derived from mice and humans. In senescent fibroblasts, replacement with mitochondria from young cells extended proliferative lifespan, whereas replacement with aged mitochondria accelerated proliferative decline, indicating bidirectional modulation of aging-associated phenotypes. In aged mouse T cells, mitochondrial genome replacement restored proliferative capacity and significantly enhanced antitumor activity following adoptive transfer into tumor-bearing mice. Similarly, mitochondrial genome replacement in aged human T cells enhanced cytokine production and shifted the transcriptomic programs toward a more youthful state. Collectively, these findings identify mitochondrial genetic integrity as a functional regulator of aging-associated cellular states and support the emerging view that mitochondria actively influence cellular aging trajectories.

Cell Biology↗

The MIRO1-BAX Complex Dictates Life and Death at the Mitochondrial Gate

BAX macropores in the outer mitochondrial membrane (OMM) are canonical mediators of apoptosis, but whether the same pore structure can drive distinct cell death pathways remains unclear. Here, we identify the OMM protein MIRO1 as a context-specific modulator of BAX activity. Mechanistically, MIRO1 binds BAX via MIRO1s N-terminal domain to promote macropore formation and the release of mitochondrial DNA (mtDNA) into the cytoplasm, triggering the STING-pIRF3 signaling axis. In glioma cells, this pathway sustains GPX4 expression via pIRF3-mediated transcriptional activation and confers ferroptosis resistance while bypassing inflammation. By contrast, in Parkinsonian neurons, the MIRO1-BAX complex promotes mitochondrial-stress-induced apoptosis. Using structure-guided drug discovery, we developed first-in-class small molecules that allosterically disrupt the MIRO1-BAX complex by engaging MIRO1s distal GTPase pocket. These compounds sensitize glioma cells to ferroptosis and protect neurons from apoptosis. Our findings reveal a disease-specific mitochondrial switch for life-death decisions and illuminate the molecular logic by which cells exploit and interpret OMM permeabilization.

Cell Biology↗